Lv5
850 积分 2021-08-20 加入
Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
1个月前
已完结
The next generation of antibody–drug conjugates
1个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
4个月前
已完结
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis
7个月前
已完结
B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities
8个月前
已完结
GDF15 in the tumor microenvironment: a central mediator of cancer immunometabolism and therapeutic resistance
9个月前
已完结
Combination targeted therapy with two biologic/targeted synthetic DMARDs in 1200 patients with immune mediated inflammatory diseases. A systematic literature review for current landscape in safety and efficacy
9个月前
已完结
Dual-targeted NAMPT inhibitors as a progressive strategy for cancer therapy
10个月前
已完结
NAMPT: A critical driver and therapeutic target for cancer
10个月前
已完结
Targeted degradation of extracellular secreted and membrane proteins
10个月前
已完结
皖公网安备34019202002308
